focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.10
Bid: 9.70
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 0.80 (8.247%)
Open: 10.10
High: 10.10
Low: 10.10
Prev. Close: 10.10
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Aptamer reshuffles board; Scancell expands trial

Mon, 31st Jul 2023 10:46

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Scancell Holdings PLC, up 25% at 11.52 pence, 12-month range 8.65p-29.40p. The cancer immunotherapies developer says it has expanded its Modi-1 trial for the use of checkpoint inhibitors on cancer patients. Scancell says the safety review committee has approved the addition of two new cohorts of 21 patients each. This move follows the successful completion of cohort four of the trial, which showed that patients with renal, head and neck cancer who received at least two doses of Modi-1 combined with CPI tolerated the treatment well, with no safety concerns.

----------

Tertiary Minerals PLC, up 12% at 0.10p, 12-month range 0.083p-0.31p. The mineral exploration and development company says it has received permission from the Forest Department of Zambia to carry out soil sampling in forested areas at its Mukai and Mushima North project licenses. The firm says it is exploring the two license areas for copper, with two targets, C1 and A1, identified at Mushima. Chair Patrick Cheetham says: "Our objective is to now complete soil sampling over the exciting targets we have developed at Mushima North and Mukai as well as at our Konkola West Project. This will enable us to prioritise our Zambian Projects for follow up drilling having already completed similar programmes at our Lubuila and Jacks Projects."

----------

AIM - LOSERS

----------

Aptamer Group PLC, down 45% at 2.64p, 12-month range 2.00p-100.00p. The provider of Optimer binders for use in therapeutics, diagnostics, bioprocessing and research says it has terminated its sale process after announcing it had conditionally completed a fundraise. The company says it conditionally raised GBP3.6 million, and accordingly the board decided to terminate the formal sale process. "The company is not in discussions with any party in relation to a sale and is not in receipt of any approaches," says Aptamer. The company also reveals that Chair Ian Gilham and Interim Chief Executive Officer & Chief Financial Officer Rob Quinn have resigned, effective from August 21. The company announced that it had appointed Steve Hull as chair from the same date, and promoted Andrew Rapson, current head of finance, to CFO.

----------

Jadestone Energy PLC, down 32% at 23.70p, 12-month range 23.00p-103.00p. The oil and gas production company focused on the Asia-Pacific region says production is temporarily shut at Montara floating production storage and offloading facility offshore Australia due to a gas alarm in tank 4S. It says the tank will be emptied, cleaned and inspected over the next few weeks. Production at Montara had only resumed in March after closing down in August of last year for repair activities. Chief Executive Officer Paul Blakeley says: "While disappointing and frustrating to have to shut in Montara again, we will find and repair any additional defect while continuing with the overall planned programme of inspection of the storage tanks on the FPSO. The safety of our personnel, as well as the long-term integrity of the asset, are paramount. We will provide a further update once the inspection of tank 4S is complete."

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
19 Feb 2021 12:40

IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares

IN BRIEF: Scancell Non-Exec Director Diggle Sells 1.3 Million Shares

Read more
17 Feb 2021 16:22

IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares

IN BRIEF: Scancell Non-Exec Director Diggle Sells GBP95,000 In Shares

Read more
3 Feb 2021 14:53

Scancell ends clinical development partnership with Cancer Research UK

(Sharecast News) - Novel immunotherapy developer Scancell updated the market on its SCIB2 clinical development partnership with Cancer Research UK on Wednesday, reporting that due to the impact of the Covid-19 pandemic and Cancer Research UK's re-evaluation of its collaboration model, the parties had agreed to end their clinical development partnership.

Read more
3 Feb 2021 11:20

CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead

CORRECT: AIM WINNERS & LOSERS: Brave Bison Charges Ahead

Read more
3 Feb 2021 11:11

AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win

AIM WINNERS & LOSERS: Brave Bison Charges Ahead On Contract Win

Read more
3 Feb 2021 09:48

Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends

Scancell Assessing SCIB2 Options As Cancer Research UK Pact Ends

Read more
29 Jan 2021 15:05

IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine

IN BRIEF: Scancell Posts Interim Pretax Loss; To Develop Virus Vaccine

Read more
21 Dec 2020 19:39

Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit

Oxford Technology VCTs In Mixed Quarter Amid Scancell Rise, Ixaris Hit

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more
18 Dec 2020 10:26

Scancell Shares Rise As It Chooses Vaccine Candidate For Development

Scancell Shares Rise As It Chooses Vaccine Candidate For Development

Read more
18 Dec 2020 10:17

Scancell selects Covid-19 vaccine candidate for development and trials

(Sharecast News) - Immunotherapy developer Scancell has selected its Covid-19 vaccine candidate 'SN14' for further development and clinical trials, it announced on Friday.

Read more
16 Dec 2020 09:21

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares

DIRECTOR DEALINGS: Scancell Non-Executive Diggle Buys 750,000 Shares

Read more
14 Dec 2020 16:59

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

UK DIRECTOR DEALINGS SUMMARY: Tracsis CFO Sells GBP480,000 In Shares

Read more
25 Nov 2020 16:44

UK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million

UK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million

Read more
17 Nov 2020 15:40

UK EXECUTIVE CHANGE SUMMARY: Naked Wines, Tissue Regenix Make US Moves

UK EXECUTIVE CHANGE SUMMARY: Naked Wines, Tissue Regenix Make US Moves

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.